Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14499114rdf:typepubmed:Citationlld:pubmed
pubmed-article:14499114lifeskim:mentionsumls-concept:C0449738lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C0028778lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C0021701lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C1417683lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C1145667lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C1328819lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C1515877lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C1711351lld:lifeskim
pubmed-article:14499114lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:14499114pubmed:issue3lld:pubmed
pubmed-article:14499114pubmed:dateCreated2003-9-22lld:pubmed
pubmed-article:14499114pubmed:abstractTextLeukocyte integrins contain an inserted (I) domain in their alpha subunits and an I-like domain in their beta(2) subunit, which directly bind ligand and regulate ligand binding, respectively. We describe a novel mechanistic class of integrin inhibitors that bind to the metal ion-dependent adhesion site of the beta(2) I-like domain and prevent its interaction with and activation of the alpha(L) I domain. The inhibitors do not bind to the alpha(L) I domain but stabilize alpha/beta subunit association and can show selectivity for alpha(L)beta(2) compared to alpha(M)beta(2). The inhibitors reveal a crucial intersection for relaying conformational signals within integrin extracellular domains. While blocking signals in one direction to the I domain, the antagonists induce the active conformation of the I-like domain and stalk domains, and thus transmit conformational signals in the other direction toward the transmembrane domains.lld:pubmed
pubmed-article:14499114pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499114pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499114pubmed:languageenglld:pubmed
pubmed-article:14499114pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499114pubmed:citationSubsetIMlld:pubmed
pubmed-article:14499114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14499114pubmed:statusMEDLINElld:pubmed
pubmed-article:14499114pubmed:monthSeplld:pubmed
pubmed-article:14499114pubmed:issn1074-7613lld:pubmed
pubmed-article:14499114pubmed:authorpubmed-author:SpringerTimot...lld:pubmed
pubmed-article:14499114pubmed:authorpubmed-author:YangWeiWlld:pubmed
pubmed-article:14499114pubmed:authorpubmed-author:Weitz-Schmidt...lld:pubmed
pubmed-article:14499114pubmed:authorpubmed-author:ShimaokaMotom...lld:pubmed
pubmed-article:14499114pubmed:authorpubmed-author:SalasAzucenaAlld:pubmed
pubmed-article:14499114pubmed:issnTypePrintlld:pubmed
pubmed-article:14499114pubmed:volume19lld:pubmed
pubmed-article:14499114pubmed:ownerNLMlld:pubmed
pubmed-article:14499114pubmed:authorsCompleteYlld:pubmed
pubmed-article:14499114pubmed:pagination391-402lld:pubmed
pubmed-article:14499114pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:14499114pubmed:meshHeadingpubmed-meshheading:14499114...lld:pubmed
pubmed-article:14499114pubmed:meshHeadingpubmed-meshheading:14499114...lld:pubmed
pubmed-article:14499114pubmed:meshHeadingpubmed-meshheading:14499114...lld:pubmed
pubmed-article:14499114pubmed:meshHeadingpubmed-meshheading:14499114...lld:pubmed
pubmed-article:14499114pubmed:meshHeadingpubmed-meshheading:14499114...lld:pubmed
pubmed-article:14499114pubmed:meshHeadingpubmed-meshheading:14499114...lld:pubmed
pubmed-article:14499114pubmed:meshHeadingpubmed-meshheading:14499114...lld:pubmed
pubmed-article:14499114pubmed:meshHeadingpubmed-meshheading:14499114...lld:pubmed
pubmed-article:14499114pubmed:meshHeadingpubmed-meshheading:14499114...lld:pubmed
pubmed-article:14499114pubmed:meshHeadingpubmed-meshheading:14499114...lld:pubmed
pubmed-article:14499114pubmed:year2003lld:pubmed
pubmed-article:14499114pubmed:articleTitleSmall molecule integrin antagonists that bind to the beta2 subunit I-like domain and activate signals in one direction and block them in the other.lld:pubmed
pubmed-article:14499114pubmed:affiliationThe CBR Institute for Biomedical Research, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA. shimaoka@cbr.med.harvard.edulld:pubmed
pubmed-article:14499114pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14499114pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:14499114pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14499114lld:pubmed